- Validation of a novel direct method to determine reduced adherence to atorvastatin therapy, European Heart Journal Cardiovascular Pharmacotherapy 2024
- The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study, Atherosclerosis Plus 2024
- A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease. A randomized trial.European Heart Journal Open, 2024
- Treatment patterns and adherence to lipid-lowering drugs during eight-year follow-up after a coronary heart disease event. Atherosclerosis, 2024
- Statin adherence in coronary outpatients: the relationship between a novel direct method and pharmacy registry data. Poster presentasjon av Jonas Pivoriunas mfl. (NORCOR gruppen). ESC Preventive Cardiology Annual Congress, 25 April – 27 April 2024 Aten – Hellas.
- Adipose tissue insulin resistance in South Asian and Nordic women after gestational diabetes mellitus. Metabolites 2024
- 2023 ESC guidelines for the mamagement of cardiovascular disease in patients with diabetes. Hjerteforum 2024 (s. 29)
- Statin adherence in coronary outpatients: a novel direct method compared with pharmacy registry data. European Journal of Preventive Cardiology 2024 (Supplement)
- Cognitive behavioural therapy for insomnia (CBT-I) in patients with coronary heart disease: a protocol for a randomized controlled trial with six months follow-up. European Journal of Preventive Cardiology 2024 (protokoll)
- The effect of atorvastatin on mevalonate levels in blood plasma in patients with coronary heart disease and muscle side effects. European Journal of Preventive Cardiology 2024 (supplement)
- 2023 ESC guidelines for the mamagement of cardiovascular disease in patients with diabetes. Hjerteforum N° 2/ 2024/ vol 37 (s. 27-31)
- N-terminal pro-B-type natriuretic peptide levels vary by ethnicity and are associated with insulin sensitivity after gestational diabetes mellitus. Cardiovascular Diabetology 2024
- Association of normal body mass index and weight loss with long-term major cardiovascular events after PCI for myocardial infarction. Scandinavian Cardiovascular Journal 2024
- Statin discontinuation: How can we improve on the multiple pathways that contribute to suboptimal statin adherence? Polish Heart Journal (Kardiologia Polska) 2024 (Brev til redaktøren)
- High discontinuation rate of statins among PCSK9i users: A nationwide study from 2015-2023. Ingrid Engebretsen, Kristina Malene Ødegaard, Sigrun Halvorsen, Christoffer Bugge, Ivar Sønbø Kristiansen, Henrik Støvring, John Munkhaugen. Oral abstract presentation at ESC European Society of Cardiology Congress 2024, London.
- Mevalonate in blood and muscle: Response to atorvastatin treatment and the relationship to statin intolerance in patients with coronary heart disease. Clinical and Translational Science 2024
- Estimation of individual lifetime cardiovascular disease risk and treatment benefit in patients with established atherosclerotic cardiovascular disease: the updated SMART-REACH2 model. European Heart Journal, Supplement. 2024
- High discontinuation rate of statins among PCSK9i users: a nationwide study from 2015-2023. European Heart Journal, Supplement. 2024
- Forhåndssamtaler om siste livsfase. Tidsskrift for Den norske legeforening 2024
- Treatment with PCSK9 monoclonal antibodies is associated with discontinuation of oral lipid lowering therapy. European Heart Journal – Quality of Care and Clinical Outcomes, 2024
- Inntrykk fra ESC Preventive Cardiology Congress, Hjerteforum N° 3/ 2024/ vol 37 (s. 3; 85-75). Fagartikkel.
- Kardiologisk forskning i Vestre Viken – sykepleieren er viktig. Hjerteposten : fagtidsskrift for NSFs landsgruppe av kardiologiske sykepleiere 2024, utgave 3, sider: 18-22. Fagartikkel ( les utklipp: Resultat #2351451 – Kardiologisk forskning i Vestre Viken – sykepleieren er viktig – Cristin).
